SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 192.97-1.6%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harrison Hickman who wrote (3261)6/3/1997 12:21:00 AM
From: bob zagorin   of 32384
 
i agree that premature release of ALRIZ news caused increase but check this news blurb which also came out today.

"Immunex Corporation (Nasdaq: IMNX) announced today a new study demonstrating that Flt-3 ligand may have a role in cancer treatment. The study results are published in the June 1 issue of the journal Nature Medicine.

In the study, Flt-3 ligand, which helps increase stem cells and dendritic cells, was administered to mice challenged with progressively growing tumors. The results showed complete regression of those tumors in a significant proportion of the mice and a decrease in tumor growth rate in the remainder."

Two questions for Henry..Is this competiton for Ligand or confirmation of science?...Is the connection close enough to affect Ligand stock price?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext